Resection tied to better survival in CRC liver metastases
An opportunity to prolong life is being missed, surgical oncologist says
Liver resection is associated with a two-year overall survival benefit in patients with colorectal-cancer liver metastases, an analysis shows.
US researchers used data from the California Cancer Registry on nearly 25,000 patients with stage IV colorectal cancer to estimate the impact of resection on their overall survival.
The procedure was associated with significantly longer survival at the one-year mark, and nearly two years’ longer overall survival (23.6 months), the researchers reported in the Annals of Surgery.
About 70% of the patients had liver metastases but only 9.8% had a liver resection, the authors noted.
